Lv617
1740 积分 2022-05-17 加入
JAK inhibitor selectivity: new opportunities, better drugs?
4小时前
已完结
Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T‐cell therapy
2天前
已完结
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
4天前
已完结
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
6天前
已完结
Outcomes Among Adult Recipients of CAR T-cell Therapy for Burkitt Lymphoma
12天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
12天前
已完结
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
14天前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
15天前
已完结
Double-negative T cells in autoimmune diseases
27天前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
1个月前
已完结
皖公网安备34019202002308
